MDXG
MIMEDX GROUP, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.20
−1.54%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$3.31
From 52W high−59.80%
Volume1.76M
Market cap$466.96M
P/E (TTM)—
P/S (TTM)1.5x
Div yield—
Key dataNov 4, 2026
Open
$3.31
From 52W high
−59.80%
Volume
1.76M
Market cap
$466.96M
ValuationView details →
P/E (Fwd)
48.5x
EV/EBITDA
−22.4x
P/E (TTM)
—
RSI (14)
21.7
MomentumView details →
1D Return
−1.54%
YTD Return
−51.85%
SummaryUpdated Sep 1, 2026
MiMedx Group, Inc. (NASDAQ:MDXG) is a biotechnology company founded in 2008 and headquartered in Marietta, Georgia. The company specializes in developing and distributing placental tissue allografts for various healthcare applications. MiMedx has established itself as a leader in the regenerative medicine space, processing human placental tissues through its proprietary PURION process to create biological products that retain the tissue's natural healing properties. The company has evolved from its early focus on wound care into a diversified portfolio serving surgical recovery, burn treatment, and other medical applications.
Similar companies
Latest newsMore news →
MiMedx Group obtained a favorable federal court ruling in the AXIOFILL regulatory classification matter during the third quarter of 2026.7d agoMiMedx Group reported its operating and financial results for the third quarter of 2026, including continued double-digit year-over-year surgical franchise volume growth and sequential and year-over-year wound care center volume growth.7d ago